# Phase 3 Bunionectomy Study

> **NCT07490496** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Cali Pharmaceuticals LLC** · enrollment: 112 (estimated)

## Conditions studied

- Postoperative Pain
- Bunion

## Interventions

- **DRUG:** CPL-01
- **DRUG:** saline placebo

## Key facts

- **NCT ID:** NCT07490496
- **Lead sponsor:** Cali Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-11-28
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07490496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07490496, "Phase 3 Bunionectomy Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07490496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*